BRPI0606484A2 - métodos para controle do intervalo qt - Google Patents
métodos para controle do intervalo qtInfo
- Publication number
- BRPI0606484A2 BRPI0606484A2 BRPI0606484-1A BRPI0606484A BRPI0606484A2 BR PI0606484 A2 BRPI0606484 A2 BR PI0606484A2 BR PI0606484 A BRPI0606484 A BR PI0606484A BR PI0606484 A2 BRPI0606484 A2 BR PI0606484A2
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- group
- phenyl
- alkyl
- control methods
- Prior art date
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 230000028161 membrane depolarization Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
MéTODOS PARA CONTROLE DO INTERVALO QT. A presente invenção refere-se a métodos de controle da despolarização e repolarização do ventrículo cardíaco e, portanto, do intervalo QT, de maneiras terapeuticamente úteis em um sujeito que compreende administrar, para o sujeito com necessidade das mesmas, uma quantidade terapeuticamente eficaz de um composto selecionado do grupo que consiste na Fórmula (I) e Fórmula (II), ou um sal ou éster farmaceuticamente aceitável do mesmo: Fórmula (I) e Fórmula (II) em que fenila é substituida em X com um a cinco átomos de halogênio selecionados do grupo que consiste em flúor, cloro, bromo e iodo; e R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~ e R~ 6~ são independentemente selecionados do grupo que consiste em hidrogênio e C~ 1~-C~ 4~ alquila; em que C~ 1~-C~ 4~ alquila é opcionalmente substituida com fenila, em que fenila é opcionalmente substituida com substituintes independentemente selcionados do grupo que consiste em halogênio, C~ 1~-C~ 4~ alquila, C~ 1~-C~ 4~ alcóxi, amina, nitro e ciano.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64544705P | 2005-01-20 | 2005-01-20 | |
| PCT/US2006/001000 WO2006078524A1 (en) | 2005-01-20 | 2006-01-11 | Methods for qt interval control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0606484A2 true BRPI0606484A2 (pt) | 2009-06-30 |
Family
ID=36147919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606484-1A BRPI0606484A2 (pt) | 2005-01-20 | 2006-01-11 | métodos para controle do intervalo qt |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7846968B2 (pt) |
| EP (1) | EP1850841A1 (pt) |
| JP (1) | JP2008528489A (pt) |
| KR (1) | KR20080025034A (pt) |
| CN (1) | CN101146527A (pt) |
| AR (1) | AR052885A1 (pt) |
| AU (1) | AU2006206778A1 (pt) |
| BR (1) | BRPI0606484A2 (pt) |
| CA (1) | CA2595599A1 (pt) |
| CR (1) | CR9322A (pt) |
| EA (1) | EA200701536A1 (pt) |
| IL (1) | IL184730A0 (pt) |
| MX (1) | MX2007008845A (pt) |
| NO (1) | NO20074175L (pt) |
| NZ (1) | NZ556497A (pt) |
| TW (1) | TW200637540A (pt) |
| WO (1) | WO2006078524A1 (pt) |
| ZA (1) | ZA200706916B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4719890B2 (ja) * | 2006-11-09 | 2011-07-06 | 国立大学法人三重大学 | トルサード・ド・ポアンツ型心室頻拍を呈するゼブラフィッシュ |
| CZ2007376A3 (cs) * | 2007-05-30 | 2008-12-10 | Ústav prístrojové techniky AV CR, v.v.i. | Zpusob analýzy ventrikulární repolarizace |
| JP2010538728A (ja) * | 2007-09-12 | 2010-12-16 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | アラーム及び動向付け機能を有するｑｔ間隔監視システム |
| US8019406B2 (en) * | 2008-03-10 | 2011-09-13 | Biotronik Crm Patent Ag | Apparatus and method to assess the risk of R-on-T event |
| FR2953410B1 (fr) * | 2009-12-09 | 2012-02-24 | Univ Claude Bernard Lyon | Compositions antivirales pharmaceutiques ou veterinaires |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN105497876B (zh) | 2014-09-24 | 2021-01-15 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物 |
| JP6954582B2 (ja) * | 2016-12-22 | 2021-10-27 | 国立大学法人滋賀医科大学 | 医薬組成物 |
| US10512620B1 (en) | 2018-08-14 | 2019-12-24 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US12396970B2 (en) | 2021-08-20 | 2025-08-26 | AltaThera Pharmaceuticals LLC | Anti-arrhythmic compositions and methods |
| US11344518B2 (en) | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
| US12117453B2 (en) | 2018-12-07 | 2024-10-15 | Washington University | Predicting patient response to sodium channel blockers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| CZ2003445A3 (cs) * | 2000-07-21 | 2004-08-18 | Ortho@Mcneilápharmaceuticalźáinc | Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy |
| MXPA03007720A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
-
2006
- 2006-01-11 JP JP2007552172A patent/JP2008528489A/ja active Pending
- 2006-01-11 MX MX2007008845A patent/MX2007008845A/es unknown
- 2006-01-11 EA EA200701536A patent/EA200701536A1/ru unknown
- 2006-01-11 AU AU2006206778A patent/AU2006206778A1/en not_active Abandoned
- 2006-01-11 CN CNA2006800089860A patent/CN101146527A/zh active Pending
- 2006-01-11 BR BRPI0606484-1A patent/BRPI0606484A2/pt not_active IP Right Cessation
- 2006-01-11 KR KR1020077018992A patent/KR20080025034A/ko not_active Ceased
- 2006-01-11 WO PCT/US2006/001000 patent/WO2006078524A1/en not_active Ceased
- 2006-01-11 US US11/329,757 patent/US7846968B2/en not_active Expired - Fee Related
- 2006-01-11 CA CA002595599A patent/CA2595599A1/en not_active Abandoned
- 2006-01-11 NZ NZ556497A patent/NZ556497A/en not_active IP Right Cessation
- 2006-01-11 EP EP06718114A patent/EP1850841A1/en not_active Withdrawn
- 2006-01-19 TW TW095101996A patent/TW200637540A/zh unknown
- 2006-01-20 AR ARP060100224A patent/AR052885A1/es not_active Application Discontinuation
-
2007
- 2007-07-19 IL IL184730A patent/IL184730A0/en unknown
- 2007-08-14 NO NO20074175A patent/NO20074175L/no not_active Application Discontinuation
- 2007-08-17 CR CR9322A patent/CR9322A/es not_active Application Discontinuation
- 2007-08-17 ZA ZA200706916A patent/ZA200706916B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007008845A (es) | 2007-11-08 |
| AR052885A1 (es) | 2007-04-11 |
| NZ556497A (en) | 2011-03-31 |
| TW200637540A (en) | 2006-11-01 |
| EA200701536A1 (ru) | 2008-02-28 |
| ZA200706916B (en) | 2009-04-29 |
| CN101146527A (zh) | 2008-03-19 |
| US20070010578A1 (en) | 2007-01-11 |
| AU2006206778A1 (en) | 2006-07-27 |
| CR9322A (es) | 2008-09-09 |
| JP2008528489A (ja) | 2008-07-31 |
| WO2006078524A1 (en) | 2006-07-27 |
| CA2595599A1 (en) | 2006-07-27 |
| NO20074175L (no) | 2007-10-11 |
| US7846968B2 (en) | 2010-12-07 |
| EP1850841A1 (en) | 2007-11-07 |
| KR20080025034A (ko) | 2008-03-19 |
| IL184730A0 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0606484A2 (pt) | métodos para controle do intervalo qt | |
| ECSP088179A (es) | Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos | |
| CO5570670A2 (es) | Pulmonar obstructiva cronica | |
| ECSP088172A (es) | Metodos para tratar la epileptogenesis | |
| CO6180427A2 (es) | Tratamiento de los trastornos generalizados del desarrollo | |
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| JP2010502730A5 (pt) | ||
| BR0209678A (pt) | Composto, processo para preparar e uso do mesmo, composição farmacêutica, e, métodos para o tratamento da dor e de distúrbios gastrintestinais funcionais | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| IL189003A0 (en) | Methods for treating substance-related disorders | |
| RU2017110211A (ru) | ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ | |
| BR112013003228A2 (pt) | composição para controle de doença de planta e uso da mesma | |
| BR0207831A (pt) | Compostos carbamato para uso na prevenção ou tratamento de distúrbios do movimento | |
| BR112014001369A2 (pt) | derivados de ácido hidroxâmico de heteroarila e uso dos mesmos no tratamento, melhora ou prevenção de doença viral | |
| BRPI0417247A (pt) | uso de compostos, métodos para controlar as pragas fora de safra, e para proteger materiais orgánicos não vivos contra pragas fora de safra, e animais contra pragas fora de safra, e, composição de isca | |
| AR036649A1 (es) | Derivados de diarilmetilen piperidina, uso de estos derivados para la manufactura de medicamentos y composicion farmaceutica | |
| BR0207644A (pt) | Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar | |
| ECSP077395A (es) | Compuesto de carbamato para utilizar en el tratamiento de padecimientos neurodegenerativos | |
| BRPI0509512A (pt) | método de tratar esquizofrenia e/ou anormalidades glicorregulatórias | |
| BR0209676A (pt) | Composto, processo para preparar o mesmo, uso de um composto, composição farmacêutica, e, métodos para o tratamento da dor, de distúrbios gastrintestinais funcionais, e da ansiedade. | |
| AR079092A1 (es) | Flavonas sustituidas por pirrolidina como radio sensibilizadores | |
| BR0207830A (pt) | Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade | |
| BR0207829A (pt) | Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos | |
| CO6180505A2 (es) | Metodos para el tratamiento de transtornos cocleares y vestibulares | |
| BG106806A (bg) | Нови съединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUI DADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2208 DE 30/04/2013. |